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On March 11, 2010, Europe lost one of its most eminent
researchers in human genetics with the death of Professor
Leena Peltonen-Palotie. She died at the age of 57 of bone
cancer. Combining basic molecular biology, population
genetics and genetic epidemiology with clinical intelli-
gence, Leena Peltonen has played a pivotal role in unrav-
elling the genetic basis of a large number of diseases.
Peltonen-Palotie was the recipient of many international
wards, including the Antoine Marfan Award, the Anders
Jahre Prize, the European van Gysel Prize for Biomedical
Research and the Eric K. Fernstro¨m Prize. She was a
member of the Scientific Council of the European Research
Council (ERC), the European Molecular Biology Organi-
zation (EMBO) and the US National Academy of Sciences,
Institute of Medicine. Leena Peltonen was an associate
editor of our Journal since 2006.
Leena Peltonen-Palotie started her career at the Uni-
versity of Oulu in Finland in 1978 where she received her
PhD title. After postdoctoral work in the USA, she returned
to the National Public Health Institute in Helsinki. She was
a Professor at the National Public Health Institute in 1991–
1994 and at the National Public Health Institute and the
University of Helsinki in 1995–1998 and again in 2002–
2003. In 1998, she moved to the University of California
Los Angeles (UCLA) where she initiated a genetic research
centre. Nine years later she returned to Europe to head the
Human Genetics group at the Wellcome Trust Sanger
Institute, UK.
Over the years, Leena Peltonen kept close ties with the
Academy of Finland, chairing the Academy of Finland’s
Research Council for Health in 1995–1997, serving as
Academy Professor in 2003–2007 and as Director of the
Centre of Excellence in Complex Disease Genetics in
2000–2007. In addition to her work at the Sanger Institute,
she was Research Director at the Institute for Molecular
Medicine Finland (FIMM). Many of the successes in her
early career were based on her research of the Finnish
Disease Catalogue. These comprise a group of Mendelian
diseases that are relatively prevalent in Finland due to
founder effects and genetic isolation but rare outside the
country. Many discoveries of recessive and dominant
mutations underlying these disorders have been translated
into valuable new diagnostic tests and some into screening
programs, impacting the lives of and clinical care for car-
riers of these mutations.
In the last decade of the previous century, the research
focus of Leena Peltonen-Palotie moved to common com-
plex diseases. The various research groups she headed
identified genetic mutations associated with dyslipidemias,
lactose intolerance, multiple sclerosis, schizophrenia,
obesity and heart diseases. One of the keys of her success
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was that she was able to bridge the fields of genetics and
epidemiology. The combination of the robustness of genetic
research with the power and expertise of large scale epide-
miological research, yielded a power house for gene dis-
covery as well as translational studies into clinical practice
and public health. With the vision that the many genetic
epidemiological cohorts in Europe were a priceless resource
for modern genetic research, she played a pivotal role in
harmonizing biobanking in Europe. Starting with uniting
Europe’s twin registries into the GenomEU twin project, she
next assembled the many population-, family- and twin
studies in the European Network for Genetic and Genomic
Epidemiology (ENGAGE) and finally initiated the Euro-
pean biobanks within the overarching Biobanking and
Biomolecular Resources Research Infrastructure (BBMRI).
Her efforts extended outside Europe with the founding of the
Public Population Project in Genomics (P3G).
The work of Leena Peltonen has been remarkable in
many ways. Where others successfully have dedicated their
life unravelling the origin of one single disease or patho-
logical process, her work arena concerned the broad topic
health and disease and the application of new technological
developments to understand the grand plan of life. Leena
Peltonen-Palotie had a true passion for genetics as well as
the ability and dedication that to stay on top in a field that is
characterized by rapid changes in technology and new
applications. She was a landmark for many of us working
in genetics research in Europe. But never static or dog-
matic, rather like other great minds in science and arts,
always developing, open to new avenues, ready to make
radical changes, shaping the field and setting the agenda.
Her talent, dedication, ambitions and successes have made
her into one of the few female role models for researchers
in Europe. Above all, Leena was a warm personality and
extremely pleasant and stimulating company. The pre-
mature death of Leena Peltonen-Palotie deprived Europe of
a creative visionary leader in genetic research.
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